Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_10605 | 2 | 0.04 | Mlig455_047968 | Neo: - Age: - |
Mlig455_047968 {REF} {Length: 297} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} {RNA815_25886} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_10605 | 2 | 0.04 | Mlig455_047968 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_047968 {REF} {Length: 297} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} {RNA815_25886} | |
2. | MligTC455_19126 | 10 | 0.2 | Mlig455_009225 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_009225 {REF} {Length: 1570} {Pfam: Galactosyltransferase [PF01762.23, score=21.4]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=50.4, Expect=1e-06]} {RNA1310_57689} {RNA815_57743} | |
3. | MligTC455_55494 | 2 | 0.05 | Mlig455_004790 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_004790 {REF} {Length: 600} {Pfam: Receptor family ligand binding region [PF01094.30, score=64.3]; Periplasmic binding protein [PF13458.8, score=19.1]} | |
4. | MligTC455_00622 | 2 | 0.05 | Mlig455_047108 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_047108 {REF} {Length: 64} {NoTransDecoderORF} | |
5. | MligTC455_37761 | 12 | 0.26 | Mlig455_014845 | Neo: - Age: - |
0.987 | - | - | - | - | 0.987 | - | Mlig455_014845 {REF} {Length: 2142} {Pfam: CUB domain [PF00431.22, score=21.3]} {RNA1310_77188} | |
6. | MligTC455_35325 | 26 | 0.54 | Mlig455_008452, Mlig455_031353, Mlig455_056519 | Neo: - Age: - |
HTR3A | 0.986 | - | - | - | - | 0.986 | - | Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010} |
7. | MligTC455_43753 | 82 | 1.71 | Mlig455_018087 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_018087 {REF} {Length: 2050} {RNA1509_20267} {RNA1310_4680} {RNA815_3273} | |
8. | MligTC455_26219 | 33 | 0.69 | Mlig455_032559 | Neo: Irradiation Age: Down-Up-Down |
0.977 | - | - | - | - | 0.977 | - | Mlig455_032559 {REF} {Length: 2476} {TRANSSPLICED} {RNA1509_38431} {RNA1310_17856.1} {RNA815_9396} | |
9. | MligTC455_22853 | 33 | 0.7 | Mlig455_019405, Mlig455_059068 | Neo: - Age: - |
0.976 | - | - | - | - | 0.976 | - | Mlig455_019405 {REF} {Length: 4200} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=66.2, Expect=9e-12]} {RNA1310_63811} Mlig455_059068 {REF} {Length: 4200} {Pfam: Integrase zinc binding domain [PF17921.3, score=58.4]; Integrase core domain [PF00665.28, score=32.8]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=63.5, Expect=1e-10]} {RNA1310_63811} |
|
10. | MligTC455_06043 | 3 | 0.06 | Mlig455_056332 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_056332 {REF} {Length: 356} {NoTransDecoderORF} | |
11. | MligTC455_33637 | 187 | 3.9 | Mlig455_027211, Mlig455_027458 | Neo: - Age: - Region-enriched R2: 3.458/0.04514 |
CHRNA10, CHRNA7 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_027211 {REF} {Length: 782} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=89.4, Expect=4e-20]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=89.4, Expect=4e-20]; ENSG00000166664, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=2e-20]; ENSG00000275917, CHRFAM7A, CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion, [Score=89.0, Expect=1e-20]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=88.6, Expect=7e-20]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=92.0, Expect=4e-21]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=81.6, Expect=9e-18]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=71.6, Expect=2e-14]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=86.3, Expect=1e-19]} {RNA1310_19147.2} {RNA815_8553.2} Mlig455_027458 {REF} {Length: 1493} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=71.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=149, Expect=1e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=133, Expect=5e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=6e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=144, Expect=7e-38]} {RNA1310_19147.2} {RNA815_8553.2} |
12. | MligTC455_06678 | 10 | 0.22 | Mlig455_051040 | Neo: - Age: - |
SLC7A1 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_051040 {REF} {Length: 1969} {Pfam: Amino acid permease [PF13520.8, score=122.2]; Amino acid permease [PF00324.23, score=107.8]; C-terminus of AA_permease [PF13906.8, score=56.1]} {Human: ENSG00000139514, SLC7A1, solute carrier family 7 member 1, [Score=297, Expect=3e-92]} {Mouse: ENSMUSG00000041313, Slc7a1, solute carrier family 7 (cationic amino acid transporter, y+ system), member 1, [Score=300, Expect=2e-93]; ENSMUSG00000022756, Slc7a4, solute carrier family 7 (cationic amino acid transporter, y+ system), member 4, [Score=297, Expect=3e-92]; ENSMUSG00000054753, AU018091, expressed sequence AU018091, [Score=290, Expect=5e-89]; ENSMUSG00000107871, AU018091, expressed sequence AU018091, [Score=290, Expect=5e-89]} {Dmel: FBgn0036984, CG13248, [Score=290, Expect=1e-89]} {Celegans: WBGene00016806, C50D2.2, [Score=293, Expect=1e-91]} {Smed: dd_Smed_v6_8652_0_4, dd_Smed_v6_8652_0_4, [Score=436, Expect=3e-147]} {RNA1310_82370} {RNA815_51664} |
13. | MligTC455_35834 | 86 | 1.8 | Mlig455_011961 | Neo: - Age: - |
CES4A | 0.964 | - | - | - | - | 0.964 | - | Mlig455_011961 {REF} {Length: 3668} {Pfam: Carboxylesterase family [PF00135.30, score=101.0]} {Human: ENSG00000172824, CES4A, carboxylesterase 4A, [Score=79.0, Expect=9e-15]} {Mouse: ENSMUSG00000050097, Ces2b, carboxyesterase 2B, [Score=81.6, Expect=1e-15]; ENSMUSG00000061825, Ces2c, carboxylesterase 2C, [Score=81.6, Expect=1e-15]} {Dmel: FBgn0004108, Nrt, Neurotactin, [RH, Score=104, Expect=7e-23]} {Celegans: WBGene00019477, K07C11.4, Carboxylic ester hydrolase, [Score=77.0, Expect=2e-14]} {Smed: dd_Smed_v6_4800_0_2, dd_Smed_v6_4800_0_2, [Score=56.6, Expect=4e-08]} {RNA1310_8940} {RNA815_4325.1} |
14. | MligTC455_14577 | 51 | 1.06 | Mlig455_024026, Mlig455_024091 | Neo: - Age: logFC(26M/2M)=-0.714 |
0.963 | - | - | - | - | 0.963 | - | Mlig455_024026 {REF} {Length: 243} {NoTransDecoderORF} {RNA1310_72624} Mlig455_024091 {REF} {Length: 2685} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.7]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=64.7, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} |
|
15. | MligTC455_49211 | 30 | 0.63 | Mlig455_044533 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_044533 {REF} {Length: 2489} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=139.7]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=62.0, Expect=5e-10]} {Smed: dd_Smed_v6_26469_0_1, dd_Smed_v6_26469_0_1, [Score=51.6, Expect=1e-07]} {RNA1509_50956} {RNA1310_27155} {RNA815_39321} | |
16. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.961 | - | - | - | - | 0.961 | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
17. | MligTC455_50029 | 35 | 0.74 | Mlig455_010619, Mlig455_010708 | Neo: - Age: - |
FOXA1 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_010619 {REF} {Length: 1170} {Pfam: Forkhead domain [PF00250.20, score=110.8]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000170608, FOXA3, forkhead box A3, [Score=164, Expect=1e-47]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=3e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=164, Expect=7e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=7e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=169, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=150, Expect=3e-42]} {Smed: dd_Smed_v6_10718_0_4, dd_Smed_v6_10718_0_4, [Score=175, Expect=2e-51]} Mlig455_010708 {REF} {Length: 1194} {Pfam: Forkhead domain [PF00250.20, score=110.9]} {Human: ENSG00000129514, FOXA1, forkhead box A1, [Score=168, Expect=3e-48]; ENSG00000125798, FOXA2, forkhead box A2, [Score=163, Expect=2e-46]; ENSG00000170608, FOXA3, forkhead box A3, [Score=163, Expect=1e-47]} {Mouse: ENSMUSG00000035451, Foxa1, forkhead box A1, [Score=167, Expect=4e-48]; ENSMUSG00000040891, Foxa3, forkhead box A3, [Score=165, Expect=2e-48]; ENSMUSG00000037025, Foxa2, forkhead box A2, [Score=164, Expect=9e-47]} {Dmel: FBgn0000659, fkh, fork head, [Score=168, Expect=2e-48]} {Celegans: WBGene00004013, pha-4, Defective pharyngeal development protein 4, [Score=151, Expect=2e-42]} {Smed: dd_Smed_v6_10718_0_3, dd_Smed_v6_10718_0_3, [Score=175, Expect=2e-51]} |
18. | MligTC455_33875 | 32 | 0.67 | Mlig455_039631 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_039631 {REF} {Length: 3055} {TRANSSPLICED} {RNA1509_14655, RNA1509_53977} {RNA1310_22046.1, RNA1509_53977} {RNA1509_53977, RNA815_8738} | |
19. | MligTC455_38997 | 19 | 0.39 | Mlig455_066918 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_066918 {REF} {Length: 1492} {NoTransDecoderORF} {RNA1509_2373} {RNA1310_20626} {RNA815_9142} | |
20. | MligTC455_12958 | 55 | 1.15 | Mlig455_055683 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_055683 {REF} {Length: 1376} | |
21. | MligTC455_31210 | 51 | 1.07 | Mlig455_028581 | Neo: - Age: Down-Up-Down |
KCNH7 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_028581 {REF} {Length: 6310} {Pfam: Ion transport protein [PF00520.33, score=119.1]; PAS domain [PF13426.9, score=52.9]; Ion channel [PF07885.18, score=45.3]; Cyclic nucleotide-binding domain [PF00027.31, score=45.2]; PAS fold [PF00989.27, score=31.5]; PAS fold [PF08447.14, score=26.5]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=820, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=810, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=808, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=820, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=808, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=806, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=766, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=746, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=793, Expect=0.0]} {RNA1509_40124} {RNA1310_20497} {RNA815_15478} |
22. | MligTC455_39022 | 18 | 0.38 | Mlig455_040588, Mlig455_062046, Mlig455_068792 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_040588 {REF} {Length: 1473} {RNA1509_21391} {RNA1310_6366} {RNA815_11612} Mlig455_062046 {REF} {Length: 802} {TRANSSPLICED} {RNA1509_21391} {RNA1310_6366} {RNA815_31706} Mlig455_068792 {REF} {Length: 1535} {TRANSSPLICED} {RNA1509_21391} {RNA1310_6366} {RNA815_11612} |
|
23. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} |